MOORE CAPITAL MANAGEMENT, LP Alnylam Pharmaceuticals, Inc. Transaction History

MOORE CAPITAL MANAGEMENT, LP portfolio value:

$4.25M
portfolio value

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 21.24K shares 4.25M $200.16 21.24K